Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance
Weighing the gold in the gold standard: challenges in HIV prevention research
Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses
Platelet function and HIV: a case–control study
N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates
Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients
HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand
Late diagnosis in the HAART era: proposed common definitions and associations with mortality
Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings
Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples
Survival of HIV-infected patients with compensated liver cirrhosis
Changes in HIV prevalence among differently educated groups in Tanzania between 2003 and 2007
HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years
Can the further clinical development of bevirimat be justified?
Should we try to eliminate HIV epidemics by using a ‘Test and Treat’ strategy?
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V
Epidemic Stevens–Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy?
Reply to ‘Quantification of HIV-1 RNA on Dried Blood Spots’ AIDS 24:475–6
Foreskin surface area and HIV acquisition
Foreskin surface area and HIV acquisition